302 related articles for article (PubMed ID: 11578150)
1. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.
Brodsky RA; Sensenbrenner LL; Smith BD; Dorr D; Seaman PJ; Lee SM; Karp JE; Brodsky I; Jones RJ
Ann Intern Med; 2001 Oct; 135(7):477-83. PubMed ID: 11578150
[TBL] [Abstract][Full Text] [Related]
2. High-dose cyclophosphamide to treat severe aplastic anemia.
Ann Intern Med; 2001 Oct; 135(7):S-1. PubMed ID: 11596572
[No Abstract] [Full Text] [Related]
3. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.
Brodsky RA; Sensenbrenner LL; Jones RJ
Blood; 1996 Jan; 87(2):491-4. PubMed ID: 8555470
[TBL] [Abstract][Full Text] [Related]
4. High-dose cyclophosphamide as salvage therapy for severe aplastic anemia.
Brodsky RA; Chen AR; Brodsky I; Jones RJ
Exp Hematol; 2004 May; 32(5):435-40. PubMed ID: 15145211
[TBL] [Abstract][Full Text] [Related]
5. Rapid and complete reconstitution of autologous haemopoiesis after cord blood infusion in treatment-naive patients with severe aplastic anemia receiving high-dose cyclophosphamide/ATG therapy.
Li Y; Sheng Z; Niu S; Ge L; Ren C; Zou Y
Eur J Haematol; 2013 Jan; 90(1):45-50. PubMed ID: 23106334
[TBL] [Abstract][Full Text] [Related]
6. High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
DeZern AE; Petri M; Drachman DB; Kerr D; Hammond ER; Kowalski J; Tsai HL; Loeb DM; Anhalt G; Wigley F; Jones RJ; Brodsky RA
Medicine (Baltimore); 2011 Mar; 90(2):89-98. PubMed ID: 21358440
[TBL] [Abstract][Full Text] [Related]
7. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Doney K; Leisenring W; Storb R; Appelbaum FR
Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
[TBL] [Abstract][Full Text] [Related]
8. Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
Brodsky RA; Petri M; Smith BD; Seifter EJ; Spivak JL; Styler M; Dang CV; Brodsky I; Jones RJ
Ann Intern Med; 1998 Dec; 129(12):1031-5. PubMed ID: 9867758
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.
Savage WJ; DeRusso PA; Resar LM; Chen AR; Higman MA; Loeb DM; Jones RJ; Brodsky RA
Pediatr Blood Cancer; 2007 Dec; 49(7):947-51. PubMed ID: 17252566
[TBL] [Abstract][Full Text] [Related]
10. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
Tisdale JF; Dunn DE; Geller N; Plante M; Nunez O; Dunbar CE; Barrett AJ; Walsh TJ; Rosenfeld SJ; Young NS
Lancet; 2000 Nov; 356(9241):1554-9. PubMed ID: 11075769
[TBL] [Abstract][Full Text] [Related]
11. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
Bacigalupo A; Bruno B; Saracco P; Di Bona E; Locasciulli A; Locatelli F; Gabbas A; Dufour C; Arcese W; Testi G; Broccia G; Carotenuto M; Coser P; Barbui T; Leoni P; Ferster A
Blood; 2000 Mar; 95(6):1931-4. PubMed ID: 10706857
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
[TBL] [Abstract][Full Text] [Related]
13. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
[TBL] [Abstract][Full Text] [Related]
14. [The use of cyclophosphane in the immunodepressive therapy of severe aplastic anemia].
Fedorovskaia NA; Istomina LA; Kopaneva TG; Iugov IuI; Timkina EN; Minakov VN; Kudriavtseva AV
Ter Arkh; 1997; 69(4):61-4. PubMed ID: 9213965
[TBL] [Abstract][Full Text] [Related]
15. High-dose cyclophosphamide for aplastic anemia and autoimmunity.
Brodsky RA
Curr Opin Oncol; 2002 Mar; 14(2):143-6. PubMed ID: 11880702
[TBL] [Abstract][Full Text] [Related]
16. High-dose cyclophosphamide treatment for refractory severe aplastic anemia in children.
Audino AN; Blatt J; Carcamo B; Castaneda V; Dinndorf P; Wang WC; Whitlock JA; Hord JD
Pediatr Blood Cancer; 2010 Feb; 54(2):269-72. PubMed ID: 19827142
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for cure after immunosuppressive therapy of aplastic anemia.
Viollier R; Tichelli A
Acta Haematol; 2000; 103(1):55-62. PubMed ID: 10705160
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in severe acquired aplastic anemia of childhood.
Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
20. [Experience in the use of allogeneic bone marrow transplantation in severe forms of aplastic anemia at the Byelorussian hematological center].
Uss AL; Zmachinskiĭ VA; Milanovich NF; Skriagin AE; Batan ZE; Dziuba EV; Mitskevich PB; Smirnova LA
Ter Arkh; 1999; 71(7):69-72. PubMed ID: 10481871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
